Osteoporosis Disease Management Demonstration Project (0000-040)

Merck Sharp & Dohme (MSD)

Status: Completed

Conditions: Osteoporosis

Treatments: Behavioral: Disease Management Assessment

Study type: Interventional

Funder types: Industry

Identifiers

NCT00145067

0000-040

2005_051

040

Details and patient eligibility

About

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.

Enrollment: 230 patients

Sex: Female

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Members of of the Kaiser Permanente Health Plan who have fractured a bone.

Exclusion criteria

• Individuals who are not members of the Kaiser Permanente Health Plan.